Cargando…
Multidimensional Contribution of Matrix Metalloproteinases to Atherosclerotic Plaque Vulnerability: Multiple Mechanisms of Inhibition to Promote Stability
The prevalence of atherosclerotic disease continues to increase, and despite significant reductions in major cardiovascular events with current medical interventions, an additional therapeutic window exists. Atherosclerotic plaque growth is a complex integration of cholesterol penetration, inflammat...
Autores principales: | Ruddy, Jean Marie, Ikonomidis, John S., Jones, Jeffrey A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196926/ https://www.ncbi.nlm.nih.gov/pubmed/27327039 http://dx.doi.org/10.1159/000446703 |
Ejemplares similares
-
Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability
por: Olejarz, Wioletta, et al.
Publicado: (2020) -
Doxycycline Stabilizes Vulnerable Plaque via Inhibiting Matrix Metalloproteinases and Attenuating Inflammation in Rabbits
por: Dong, Mei, et al.
Publicado: (2012) -
The Role of Matrix Metalloproteinase-9 in Atherosclerotic Plaque Instability
por: Li, Tiewei, et al.
Publicado: (2020) -
Impact of PCSK9 Inhibition on Proinflammatory Cytokines and Matrix Metalloproteinases Release in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Basiak, Marcin, et al.
Publicado: (2022) -
Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022)